Panel Members’ Final Thoughts

We ended by asking each panelist for one final takeaway. Their advice emphasizes keeping safety and efficacy at the forefront and advocates for broader adoption of FDA-authorized UV devices—along with leadership attention and accountability. Champion the science, verify the authorization, and create a better environment for patients and staff.